Proteobiotics represent a novel frontier in gut health, merging the benefits of probiotics and prebiotics. Unlike traditional probiotics that introduce live beneficial bacteria, proteobiotics focus on fostering the growth of specific bacteria strains within the Proteobacteria phylum, known for their diverse metabolic capabilities and potential health benefits. These bacteria play crucial roles in digestion, immune function, and nutrient absorption. By selectively nourishing these bacteria with prebiotics, proteobiotics aim to rebalance gut microbiota, potentially offering targeted therapeutic solutions for various health conditions. Research into proteobiotics is still in its early stages, but initial studies suggest promising outcomes, including improved gastrointestinal health and enhanced immune function. As scientists delve deeper into this emerging field, proteobiotics hold exciting potential for personalized approaches to gut health and overall well-being.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India